These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16403712)

  • 1. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
    Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
    Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
    Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with a minimized extracorporeal bypass system: is there a clinical benefit?
    Abdel-Rahman U; Ozaslan F; Risteski PS; Martens S; Moritz A; Al Daraghmeh A; Keller H; Wimmer-Greinecker G
    Ann Thorac Surg; 2005 Jul; 80(1):238-43. PubMed ID: 15975373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study.
    Vedin J; Antovic A; Ericsson A; Vaage J
    Ann Thorac Surg; 2005 Aug; 80(2):586-93. PubMed ID: 16039210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal impact on inflammation and coagulation but loss of safety margins.
    Nollert G; Schwabenland I; Maktav D; Kur F; Christ F; Fraunberger P; Reichart B; Vicol C
    Ann Thorac Surg; 2005 Dec; 80(6):2326-32. PubMed ID: 16305899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.
    Paulitsch FS; Schneider D; Sobel BE; Rached R; Ramires J; Jatene F; Stolf N; Hueb W; Lopes NH
    Coron Artery Dis; 2009 Mar; 20(2):100-5. PubMed ID: 19293667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biocompatible cardiopulmonary bypass strategy to reduce hemostatic and inflammatory alterations: a randomized controlled trial.
    Paparella D; Scrascia G; Rotunno C; Marraudino N; Guida P; De Palo M; Rubino G; Cappabianca G
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):557-62. PubMed ID: 22658688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass.
    Remadi JP; Rakotoarivelo Z; Marticho P; Benamar A
    Am Heart J; 2006 Jan; 151(1):198. PubMed ID: 16368318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial.
    Sakwa MP; Emery RW; Shannon FL; Altshuler JM; Mitchell D; Zwada D; Holter AR
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):481-5. PubMed ID: 19185173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile perfusion with intra-aortic balloon pumping ameliorates whole body response to cardiopulmonary bypass in the elderly.
    Onorati F; Santarpino G; Presta P; Caroleo S; Abdalla K; Santangelo E; Gulletta E; Fuiano G; Costanzo FS; Renzulli A
    Crit Care Med; 2009 Mar; 37(3):902-11. PubMed ID: 19237895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of using a minimal extracorporeal circulation system during coronary artery bypass grafting.
    Liu Y; Tao L; Wang X; Cui H; Chen X; Ji B
    Perfusion; 2012 Jan; 27(1):83-9. PubMed ID: 21987667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
    Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
    Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.